Buyers should identify the few part characteristics whose variation could cause a safety, regulatory, assembly, sealing, or primary-function failure, then define how each will be measured and controlled. An injection molding CTQ is not every tight dimension. It is a measurable, risk-linked requirement that tells the supplier and buyer where inspection, process evidence, and escalation deserve priority.
A useful CTQ connects the released requirement, datum logic, measurement method, acceptance decision, control stage, and change trigger.
01
H2: Identify CTQs from failure consequence, not drawing density
Critical to quality means a characteristic that must perform for the buyer’s intended use. In a molded part, it may be a seal land, connector interface, locating feature, latch engagement, safety-related wall, or controlled cosmetic zone. Prioritize it because variation has a meaningful consequence, not simply because it is difficult to mold or has a narrow tolerance. ASQ describes CTQ flowdown as linking high-level objectives to measurements, which is a useful model for turning a purchasing requirement into an inspectable requirement (Reference 1).
Ask what happens if each candidate feature drifts: failed assembly, leakage, binding, loss of clearance, poor appearance, or a field-service issue. Consider severity, likelihood of variation, and detectability before shipment. A serious but hard-to-detect failure should outrank a minor dimension. Keep the list short; calling every feature a CTQ removes focus.
H3: Revisit the register after trial learning, assembly feedback, a material change, or a design revision. CTQ status is a controlled purchasing decision, not a permanent label.
02
H2: Make every CTQ measurable and decision-ready
For each CTQ, record the released revision, feature and functional intent, governing requirement, datum reference frame, limits, method, acceptance rule, inspection stage, retained record, and failure response. Add material or conditioning state where relevant. This prevents informal interpretations of ‘critical.’
Avoid instructions such as ‘check fit.’ Define the mating part or functional gauge, part condition, pass/fail rule, and owner for borderline results. For appearance, use approved limit samples or a written viewing condition. Pair seal or snap requirements with a functional check where needed. The method must fit the decision: calipers may suit a broad outside dimension, while a datum-based location may need a CMM, fixture, or functional gauge.
03
H2: Use injection molding GD&T to protect function and interfaces
Injection molding GD&T is useful when size limits alone do not protect the relationship between features. A hole can meet its diameter limit and still be in the wrong location for assembly. Position, profile, flatness, or perpendicularity may better express the functional need. Point each CTQ to the released drawing or model revision that governs it, and make clear whether the 2D drawing or model-based definition controls acceptance.
Datum logic matters because shrinkage, warpage, part restraint, and setup can change a reported result. Define the locating surfaces, support for flexible parts, and whether the check is free-state or fixture-constrained. NIST notes that product and manufacturing information can include GD&T, texture, finish, materials, and process notes, and that semantic PMI can support CAD, manufacturing, and CMM workflows (Reference 2). If a model carries PMI, ask the supplier to confirm that the released information is usable in its inspection workflow; do not assume a model viewer is an acceptance system.
| Priority | Typical CTQ consequence | Inspection and control focus | Buyer risk if weak |
|---|---|---|---|
| High | Safety, compliance, primary function, sealing, or critical interface failure | Feasibility review, functional or datum-based method, first-article evidence, production control, containment and change notification | A defect can reach assembly or end use before a final check finds it |
| Medium | Fit, usability, durability, or important appearance failure | Defined method, planned lot or production verification, traceable acceptance record | Rework, returns, or inconsistent assembly |
| Standard | Low-consequence size or appearance variation | Appropriate routine dimensional or visual inspection | Excess reporting can distract from actual CTQs |
04
H2: Evaluate supplier evidence, not just an inspection-report template
At tool trial, confirm whether the feature can be produced under stated material, tool, and process conditions. At first article, confirm the result and method. During production, verify that records identify the revision, lot, cavity where relevant, and disposition. A first-article result does not prove later lots will conform.
Ask suppliers for a CTQ-linked inspection plan, a sample report with method and traceability, and a failed-CTQ procedure. This evidence-first approach reduces dependence on distance and unsupported assurances across Europe, the United States, and the Middle East. Inspection frequency should follow consequence, process evidence, and detectability. Do not require 100% measurement by default; it may be impractical or damaging and does not stabilize an uncontrolled process.
| Supplier response | Evidence supplied | Quality and supply risk | Buyer next step |
|---|---|---|---|
| Generic final inspection | Dimensions only; no CTQ link, datum setup, sampling basis, or change rule | High: critical features may be checked inconsistently or too late | Request a CTQ-linked plan before release |
| Drawing-led inspection | First-article measurements and a method, but limited routine-control detail | Moderate: launch evidence may not become ongoing control | Clarify production verification, containment, records, and notification |
| CTQ-controlled proposal | Register, method, traceable evidence, response to nonconformance and change | Lower avoidable ambiguity; suitability still depends on the application and performance | Review against the part risk and include agreed evidence in the RFQ or quality agreement |
05
H2: Link CTQs to process validation and controlled change
Injection molding process validation should examine the intended production route, not just an acceptable-looking trial shot. Agree the material grade and condition, tool and cavity configuration, CTQ method, sample identification, functional testing where needed, and acceptance route before the trial. The scope must match the product risk, contract, and applicable obligations; there is no universal sample size or capability target that fits every program.
FDA process-validation guidance is written for drugs, but says its lifecycle principles and approaches can be used by all manufacturers (Reference 3). Buyers can apply that disciplined logic without claiming a certification or importing pharmaceutical requirements automatically: establish the intended process, obtain agreed evidence, and maintain control when conditions change. Set triggers for resin or colorant changes, mold repair affecting a feature, tool transfer, cavity addition, major process or fixture changes, drawing revisions, and repeated adverse trends. For each, state whether notification, added inspection, revalidation, or buyer approval is required.
06
H2: Put the CTQ plan into the RFQ before supplier award
Include released CAD and drawings, material and color requirements, application information, CTQ register, GD&T clarification, cosmetic criteria, requested first-article evidence, packaging needs, and change-notification expectations in the injection molding RFQ. Ask suppliers to identify measurement, tooling, or molding risks. A documented exception before award is more useful than a late discovery after tooling begins.
Ready to create a risk-based inspection package? Request a quote with your part files and the characteristics that cannot fail in service. InjeForm can use the submitted requirements as a basis for a manufacturing and quality discussion; buyers should confirm the final inspection and acceptance plan against their own product, contractual, and regulatory obligations before release.
Practical takeaway
Before you move
to the next review.
- Rank candidate CTQs by functional consequence, likelihood of variation, and detectability before shipment.
- Record the released revision, feature, datum logic, method, acceptance rule, owner, and escalation response for each CTQ.
- Confirm that the measurement setup suits the tolerance, part condition, and intended functional decision.
- Request first-article and routine-control evidence traceable to the revision, lot or sample, and cavity where relevant.
- Agree containment, deviation approval, change notification, and revalidation triggers before purchase release.
- Review CTQs after a design, material, tool, process, fixture, or performance change.
FAQ
Common questions
What is an injection molding CTQ?
An injection molding CTQ is a measurable product or process characteristic whose variation could materially affect an agreed outcome, such as function, fit, sealing, safety, compliance, or controlled appearance. It should have an objective requirement and acceptance decision.
Are all tight tolerances CTQs?
No. CTQ status depends on functional consequence, variation risk, and detectability. A wider requirement can be a CTQ when its loss prevents assembly or intended use, while some tight dimensions may be routine controls.
How does injection molding GD&T support CTQ inspection?
GD&T can define the datum-based relationship needed for a functional interface. It helps prevent a part from passing separate size checks while failing feature location, profile, or orientation required for assembly.
Should every CTQ receive 100% inspection?
Not automatically. The appropriate strategy depends on consequence, process evidence, measurement feasibility, and defect detectability. Require a justified plan and strengthen it where the risk of escape is high.
What should trigger additional injection molding process validation?
Assess changes that could affect a CTQ, including material, tool, cavity, process, gauge or fixture, drawing revision, or repeated adverse trend. The agreed plan should define when notification, added evidence, revalidation, or buyer approval is needed.
References
Source material
- [1] ASQ, The CTQ Flowdown as a Conceptual Model of Project Objectives
- [2] National Institute of Standards and Technology, MBE PMI Validation and Conformance Testing Project
- [3] U.S. Food and Drug Administration, Process Validation: General Principles and Practices
This guide is general information for early procurement and engineering discussion. It does not replace product-specific DFM, qualification, validation, regulatory assessment or legal advice.